Table 2 Meta-analysis of maternal and perinatal outcomes in studies comparing COVID-19 vaccinated and unvaccinated pregnancies.

From: Systematic review and meta-analysis of the effectiveness and perinatal outcomes of COVID-19 vaccination in pregnancy

Outcome

Studies (n)

Vaccinated (n)

Unvaccinated (n)

Effect estimate*

P

I2 (%)

Miscarriage

227,29

15,684

108,249

1.00 (0.92– 1.09)

0.988

19.8

Fetal anomalies

28,20

335

523

0.91 (0.40– 2.06)

0.820

0.0

Stillbirth

78,21,24,30,31,32,33

66,067

425,624

0.85 (0.73–0.99)

0.035

93.9

GA at birth

48,24,31,34

3145

6375

−0.04 (−0.30 to 0.29)

0.966

85.3

PTB < 37 weeks’ gestation

68,24,28,31,32,33

37,195

369,924

0.89 (0.73– 1.09)

0.269

96.8

PTB < 34 weeks’ gestation

28,31

845

1462

0.88 (0.53– 1.48)

0.634

0.0

PTB < 32 weeks’ gestation

38,32,33

25,032

331,419

0.81 (0.34–1.92)

0.627

56.6

PTB < 37 weeks’ gestation adjusted for time-varying confounding

28,28

10,197

36,414

0.90 (CI 0.81–1.00)

0.051

0.0

Low BW (<2500 g)

232,33

24,899

331,020

0.99 (0.93–1.04)

0.621

0.0

SGA at birth

48,28,31,34

10,686

36,647

1·00 (0·93 – 1·08)

0.918

16.9

BW, Z-score

28,19

219

461

0.0 (−0.17 to 0.18)

0.956

0.0

BW, grams

324,31,34

3012

5976

−5.88 (−28.8 to 16.0)

0.598

0.0

Asphyxia

231,32

852

2925

0.29 (0.09–1.00)

0.049

0.0

5-min Apgar score < 7

331,32,34

1765

6411

0.78 (0.37– 1.61)

0.499

46.7

NICU admission

38,31,32

985

3324

0.94 (0.63– 1.40)

0.764

0.0

  1. All P values are two-sided without any adjustments. Effects estimates were pooled using one of the following estimators (maximum-likelihood, restricted maximum-likelihood, inverse variance)
  2. BW birthweight, GA gestational age, n number, NICU neonatal intensive care unit, PTB preterm birth, SGA small for gestational age
  3. aEffect estimates are reported as odds ratio (binary outcomes), mean difference (continuous outcomes), hazard ratio (preterm birth adjusted for time varying confounding and 95% confidence intervals.